From Science to Clinical Practice: Advancing Heart Failure Care with ReDS™ Pro

Featured Event

Sensible Medical Named One of the TIME’s World’s Top HealthTech Companies 2025

We are honored to share that Sensible Medical has been recognized by TIME as one of the World’s Top HealthTech Companies in 2025.

This prestigious recognition places Sensible among 400 global leading companies that are shaping the future of healthcare through innovation and global impact.

Being included reflects the technological and clinical value of the ReDSTM Pro System which provides non-invasive assessment pulmonary congestion and allows enhanced decision-making in heart failure management leading to reduction in hospital readmissions.

We remain committed to advancing patient-centered solutions and we thank our partners and customers for making this milestone possible.

https://time.com/7318020/worlds-top-healthtech-companies-2025/

News

NEWS

Sensible Medical Named One of the TIME’s World’s Top HealthTech Companies 2025

NEWS

Sensible Marks World Heart Day 2025: Supporting Better Heart Failure Care

On 29 September, the world unites to mark World Heart Day, a global initiative led by the World Heart Federation to raise awareness and inspire action for cardiovascular health.

The 2025 theme, “Don’t miss a beat”, emphasizes the importance of early detection, awareness, and continuous care.

At Sensible Medical, we are proud to join in marking this important day.

Our solution, the ReDS™ Pro System, is a non-invasive technology aimed to support heart failure management and help reduce hospital readmissions

by providing clinicians with actionable insights into pulmonary congestion.

On this World Heart Day, we reaffirm our commitment to advancing patient-centered solutions

with the aim of empowering better decision-making in heart failure care.

Learn more about the global campaign: world-heart-federation.org/world-heart-day

NEWS

Sensible Medical Achieves Major Milestone in Veteran Care

We’re proud to share an important milestone for Sensible Medical in advancing care for U.S. veterans.

Our ReDS Pro system continues to advance the management of heart failure and pulmonary congestion.

A Major Milestone for Veteran Care – Sensible Medical’s ReDS™ System Now Available Through Federal Supply Schedule for VA Medical Facilities in the US

NEWS

We are pleased to announce our collaboration with Wellesta for commercialization the ReDS™ Pro in Southeast Asia (SEA) and India.

This partnership marks a significant step in expanding access to ReDS™ technology across new territories, enabling clinicians to assess easily pulmonary congestion across the continuum of care and optimize the management of their heart failure patients.

Together with Wellesta’s strong market presence, established reputation and expertise in healthcare distribution, we are excited to deliver innovative solutions that drive improved outcomes for both patients and healthcare providers.

NEWS

Welcome to the next edition of the ReDS Newsletter!

In this issue, we bring you the latest updates and insights from the world of ReDS.
Stay tuned for important news and upcoming events.

ReDS Newsletter – New edition

NEWS

Welcome to our ReDS Newsletter – November 2024!

Get ready to dive into the latest news and research and explore our activities around the world.

ReDS Newsletter – November 2024

Events

EVENTS

Join Sensible Medical at HFSA 2025 in Minneapolis!

Sep 26–29 Minneapolis

Visit us at booth #220 for live ReDS™ Pro demos,

discover how to quickly assess pulmonary congestion,

and explore ReDS-guided management for better outcomes.

We will also participate at the “Devices in Heart Failure: Mechanisms & Implementation” meeting on the first day.

See you there!

Visit us at booth #220 for live ReDS™ Pro demos, discover how to quickly assess pulmonary congestion, and explore ReDS-guided management for better outcomes. We will also participate at the “Devices in Heart Failure: Mechanisms & Implementation” meeting on the first day. See you there!

EVENTS

Join Sensible Medical at HFA 2025 in Belgrade!

We will be participating in Heart Failure 2025, the annual meeting of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Visit us at booth (#A0) to experience the ReDS™ Pro System — a non-invasive, evidence-based solution for pulmonary congestion assessment in heart failure patients.

Discover how ReDS™ Pro can optimize heart failure care and help improve patient outcomes.

Let’s advance heart failure care together!

We will be participating in Heart Failure 2025, the annual meeting of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Visit us at booth (#A0) to experience the ReDS™ Pro System — a non-invasive, evidence-based solution for pulmonary congestion assessment in heart failure patients. Discover how ReDS™ Pro can optimize heart failure care and help improve patient outcomes. Let’s advance heart failure care together!